|
|||||
|
|
Mizoribine requires individual dosing due to variation of bioavailability |
|
| Authors: | Toshiya Fuke Yoshifusa Abe Satoshi Hibino Mikawa Takeshi Takako Saito Shunsuke Sakurai Shuichiro Watanabe Jun‐Ichiro Murayama Kazuo Itabashi Yasuko Nakano |
| Affiliation: | 1. Department of Hospital Pharmaceutics, School of Pharmacy, , Japan;2. Department of Pharmacogenomics, School of Pharmacy, , Japan;3. Department of Pediatrics, Showa University, , Japan;4. Watanabe Children's Clinic, , Tokyo, Japan |
| Abstract: | |
| Keywords: | bioavailability glomerular disease linearity mizoribine pharmacokinetics |